Document is current

Article History

Received: 5 January 2023

Accepted: 19 February 2023

First Online: 18 March 2023

Declarations

: All declarations of interest are outside the submitted work.

: • Peter Humaidan reports reception of lecture honoraria from Merck, Gedoeon Richter and IBSA.

: • Antonio La Marca reports reception of consulting fees from Merck, Organon, Ferring, Gedeon Richter, Theramex, Beckman Coulter, and Roche.

: • Samuel Santos-Ribeiro reports reception of research funding from Roche diagnostics, Organon and Theramex; reception of consulting fees from Organon, MSD and Ferring; honoraria for lectures from Ferring, Besins, MSD/Organon, Theramex and Gedeon Richter; reception of equipment materials or other services from Roche diagnostics and Ferring and is deputy of the SQART SIG in ESHRE.

: • Alessandro Conforti reports reception of grants from the University of Naples Federico II; recpetion honoraria from Medea, Event Planet and Merck.

: • Baris Ata – reports reception of consulting fees from Merck GmBH – Turkey, reception of payment or honoraria from Abbott, Merck GmBH and Ferring; reception of support for attending meetings or travel from IBSA; is president of the Turkish Society of Reproductive Medicine and is an executive committee member of ESHRE.

: • Juan Garcia Velasco – reports reception of payment or honoraria for lectures or educational events from Merck, Ferring, MSD, Organon, Theramex and Gedeon Richter.

: • George Lainas—reports reception of payment or honoraria for lectures or educational events from Merck and Ferring, payment for expert testimony from Merck and support for attending meetings from ESHRE. He also participated in data safety monitoring or advisory board of Merck.

: • Filippo Maria Ubaldi is the scientific director of GeneraLife and minority shareholder of the company. He is also president of SIFES-MR (the Italian Society of Fertility, Sterility and Reproductive Medicine), and member of the scientific board of Medea. In the last three years, F.M. Ubaldi has received honoraria or consultation fees from Merck, MSD, Ferring, Gedeon Richter, Organon and Ibsa.

: • Sesh Sunkara reports reception of payment or honoraria for lectured from, Merck Ferring and MSD.

: • Raoul Orvieto reports reception of consulting fees from Merck and Ferring and payment or honoraria for lectures from Merck and Ferring.

: • Nikolaos Polyzos reports reception of grants or contracts from Merck Serono, IBSA, Organon, Ferring, Roche, Theramex, Besins Healthcare and Gedeon Richter and reception of consulting fees from Merck Serono, IBSA, Organon, Ferring, Besins Healthcare and Gedeon Richter.

: • Ben Mol reports reception of an investigator grant from NHMRC, he reports consultancy at an hourly rate for ObsEva, Merck Merck KGaA and Guerbet and reception of travel support from Merck Merck KGaA.

: • Hakan Yarali reports unrestricted grants from Merck, honoraria for lectures from Merck and IBSA, support for attending meetings from Merck, IBSA and Ferring.

: • Human Fatemi reports receiving research grants from Merck Serono and Organon, consulting fees from Ferring global, speaker honoraria from Organon, Merck Serono and Ferring and participation in data safety monitoring or advisory board for Ferring.

: • Sandro Esteves reports unrestricted research grants from Merck KGaA, reception of consulting fees from Merck, MeD.E.A and event planet, reception of honoraria for lectures from Merck, MeD.E.A and event planet, has a patent on the ART calculator, is an unpaid advisory board member for Nature Reviews and for Urology, Is the Head, Department of Education and Research, Brazilian Society of Urology (São Paulo section; unpaid) and is the Co-chair, Male Infertility Special Interest Group, WHO Infertility Guidelines (unpaid).

: • Ariel Weissman reports no conflicts of interest.• Christophe Blockeel reports no conflicts of interest.• Seang Lin Tan reports no conflicts of interest.• Michael Dahan reports no conflicts of interest.• Bulent Urman reports no conflicts of interest.• RJ Norman reports no conflict of interest.• Richard Paulson reports no conflicts of interest.• Ido Feferkorn reports no conflicts of interest.